These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

725 related items for PubMed ID: 6781938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI, Das RP, Madoiya KK, Jain AK, Roy S.
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [Abstract] [Full Text] [Related]

  • 9. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Nov 01; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 11. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B, Zeng T, Wu S, Sun H, Xiao N.
    Contraception; 1995 Jun 01; 51(6):359-65. PubMed ID: 7554977
    [Abstract] [Full Text] [Related]

  • 12. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE, Kettel LM, Yen SS.
    Fertil Steril; 1992 Aug 01; 58(2):338-43. PubMed ID: 1633899
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravaginal contraception with the synthetic progestin, R2010.
    Toivonen J.
    Contraception; 1979 Nov 01; 20(5):511-8. PubMed ID: 527342
    [Abstract] [Full Text] [Related]

  • 15. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
    Laumas V, Jain AK, Jha P, Rahman SA, Kumar D, Malik BK, Sarkar NN, Takkar D, Hingorani V, Laumas KR.
    Contraception; 1981 Feb 01; 23(2):211-25. PubMed ID: 6786828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R, Osman P, Dullaart J, de Greef WJ, Uilenbroek JT, de Jong FH.
    J Endocrinol; 1975 Jan 01; 64(1):37-47. PubMed ID: 1167896
    [Abstract] [Full Text] [Related]

  • 18. Effect of a once weekly oral contraceptive upon gonadotrophin and gonadal steroid levels.
    Tredway DR, Mishell DR.
    Contraception; 1974 Aug 01; 10(2):159-69. PubMed ID: 4418460
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.
    Am J Obstet Gynecol; 1995 Sep 01; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.